sector
India’s Pharmaceutical Sector 2026: Strategic Transformation to a ₹17.33 Lakh Crore Powerhouse
India’s pharmaceutical sector is undergoing a massive shift from low-margin generics to high-value specialty medicines and biosimilars. With a market capitalization of ₹17.33 lakh crore, the sector faces near-term trade headwinds but offers significant long-term opportunities in GLP-1 therapies and CDMO services.